2. Academic Validation
  3. Erlotinib synergizes with the poly(ADP-ribose) glycohydrolase inhibitor ethacridine in acute myeloid leukemia cells

Erlotinib synergizes with the poly(ADP-ribose) glycohydrolase inhibitor ethacridine in acute myeloid leukemia cells

  • Haematologica. 2016 Nov;101(11):e449-e453. doi: 10.3324/haematol.2016.146894.
Lianne E Rotin 1 2,  Neil MacLean 1,  Ahmed Aman 3,  Marcela Gronda 1,  Feng-Hsu Lin 1,  Rose Hurren 1,  XiaoMing Wang 1,  Jeffrey L Wrana 4,  Alessandro Datti 4 5,  Rima Al-Awar 3 6,  Mark D Minden 1 2,  Aaron D Schimmer 7 2
Affiliations

Affiliations

  • 1 Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada.
  • 2 Institute of Medical Science, University of Toronto, ON, Canada.
  • 3 Drug Discovery Program, Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • 4 Samuel Lunenfeld Research Institute, Toronto, ON, Canada.
  • 5 Department of Agricultural, Food, and Environmental Sciences, University of Perugia, Italy.
  • 6 Department of Pharmacology and Toxicology, University of Toronto, ON, Canada.
  • 7 Princess Margaret Cancer Centre, Ontario Cancer Institute, University Health Network, Toronto, ON, Canada aaron.schimmer@utoronto.ca.
PMID: 27587383 DOI: 10.3324/haematol.2016.146894
Figures
Products